BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 178170)

  • 1. Decreased T-lymphocytes in patients with mammary cancer.
    Keller SE; Ioachim HL; Pearse T; Siletti DM
    Am J Clin Pathol; 1976 Apr; 65(4):445-9. PubMed ID: 178170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Search for disease-related cytotoxicity in mammary tumor patients.
    Bakacs T; Klein E; Ljungström KG
    Cancer Lett; 1978 Apr; 4(4):191-7. PubMed ID: 206348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of T-cell population in carcinoma breast.
    Nirwan PS; Ramdeo IN; Solanki RL
    Indian J Cancer; 1980 Dec; 17(4):210-5. PubMed ID: 6262220
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of breast cancer transcortin and its inhibitory role in cell-mediated immunity.
    Amaral L; Werthamer S
    Nature; 1976 Aug; 262(5569):589-90. PubMed ID: 8726
    [No Abstract]   [Full Text] [Related]  

  • 5. Establishment of monoclonal antibodies reactive with epithelial and myoepithelial cells in the breast.
    Imai S; Sekiya N; Morimoto J; Kiyozuka Y; Tsubura Y; Sakamoto G
    Acta Pathol Jpn; 1986 Sep; 36(9):1319-26. PubMed ID: 3024448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphoid cells in the venous blood of 100 female patients with breast carcinoma. Follow-up studies].
    Lellé RJ; Heidenreich W; Peter HH
    Onkologie; 1985 Aug; 8(4):241-5. PubMed ID: 3005936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of radiotherapy on lymphocyte cytotoxicity in vitro.
    Wasserman J; Melén B; Blomgren H; Glas U; Perlmann P
    Clin Exp Immunol; 1975 Nov; 22(2):230-9. PubMed ID: 1082400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ABO(H) cell surface antigens in carcinoma and benign lesions of the breast.
    Shull JH; Javadpour N; Soares T; Demoss EV
    J Surg Oncol; 1981; 18(2):193-6. PubMed ID: 7300366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibody in patients with mammary disease.
    Humphrey LJ; Estes NC; Morse PA; Jewell WR; Boudet RA; Hudson MJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1516-20. PubMed ID: 4214083
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell mediated immune status in carcinoma breast.
    Mohanty I; Nayak M; Nanda BK
    Indian J Pathol Microbiol; 1991 Jan; 34(1):1-6. PubMed ID: 1665479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-biopsy breast carcinoma: a natural experiment in cancer immunology.
    Black MM; Cutler SJ; Barclay TH
    Cancer; 1972 Jan; 29(1):61-5. PubMed ID: 4332318
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic response and prognosis in patients with breast cancer. II. Prognostic value of morphological and functional indicators of cellular response].
    Smolak K
    Nowotwory; 1984; 34(1):21-30. PubMed ID: 6330700
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoantigens A, B and H in benign and malignant lesions of breast.
    Gupta RK; Schuster R
    Am J Pathol; 1973 Aug; 72(2):253-7. PubMed ID: 4807589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study on the distribution and significance of mononuclear cells in human breast carcinoma.
    Tanaka H; Shimoda T; Uchida K; Suzuki T; Ishikawa E
    Acta Pathol Jpn; 1986 Oct; 36(10):1455-68. PubMed ID: 3026138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "T" lymphocytes in breast tumors.
    Ramani S; Subhashini AV
    Indian J Physiol Pharmacol; 1992 Jan; 36(1):73-4. PubMed ID: 1317822
    [No Abstract]   [Full Text] [Related]  

  • 16. An antitumor antibody in normal human serum: reaction of anti-T with breast carcinoma cells.
    Howard DR; Taylor CR
    Oncology; 1980; 37(3):142-8. PubMed ID: 6244524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The secretory IgA system and breast cancer].
    Rossiello R; Carriero MV; Bevilacqua AM; Di Costanzo MR; Di Bonito M
    Pathologica; 1984; 76(1042):201-9. PubMed ID: 6089080
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemical study of D5 antigen (an oestrogen receptor related protein) in normal breast, benign breast disease, and mammary carcinoma in situ.
    Girling A; Caleffi M; King RJ; Millis RR
    J Clin Pathol; 1988 Apr; 41(4):448-53. PubMed ID: 2835402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disorders of the immune system in benign lesions and cancer of the breast].
    Derevnina NA; Polevaia EB; Veskova TK; Trubcheninova LP; Bogatyrev VN
    Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of immuno-electron microscopy to the cytologic study of benign and malignant mammary lesions. With special reference to the carcinoembryonic antigen localization patterns.
    Yamamoto Y; Yasumura K; Murakoshi M; Abe H; Furukawa S; Osamura RY; Watanabe K
    Acta Cytol; 1985; 29(3):257-61. PubMed ID: 2988246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.